

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cell migration in hindbrain (GO:0021535) | 4.08963554 |
| 2 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.01631818 |
| 3 | synaptic vesicle maturation (GO:0016188) | 3.99671518 |
| 4 | polarized epithelial cell differentiation (GO:0030859) | 3.93599749 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.88230809 |
| 6 | negative regulation of cell killing (GO:0031342) | 3.85612772 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.85612772 |
| 8 | sodium ion export (GO:0071436) | 3.81087061 |
| 9 | plasma membrane repair (GO:0001778) | 3.78369501 |
| 10 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.74707330 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 3.74092508 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 3.74092508 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.74092508 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.74092508 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.74092508 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 3.74092508 |
| 17 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.72664372 |
| 18 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.72297797 |
| 19 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.70372349 |
| 20 | locomotory exploration behavior (GO:0035641) | 3.66001448 |
| 21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.60110940 |
| 22 | negative regulation of cell size (GO:0045792) | 3.59394828 |
| 23 | layer formation in cerebral cortex (GO:0021819) | 3.57875518 |
| 24 | cell communication by electrical coupling (GO:0010644) | 3.55005618 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.52493826 |
| 26 | negative regulation of microtubule polymerization (GO:0031115) | 3.47931116 |
| 27 | detection of other organism (GO:0098543) | 3.45231127 |
| 28 | stress fiber assembly (GO:0043149) | 3.41026967 |
| 29 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.34131871 |
| 30 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.31039370 |
| 31 | detection of bacterium (GO:0016045) | 3.28611103 |
| 32 | cell communication involved in cardiac conduction (GO:0086065) | 3.26310004 |
| 33 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.22399074 |
| 34 | activation of protein kinase A activity (GO:0034199) | 3.21214189 |
| 35 | barbed-end actin filament capping (GO:0051016) | 3.15879857 |
| 36 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.15808367 |
| 37 | response to peptidoglycan (GO:0032494) | 3.15726771 |
| 38 | synaptic vesicle exocytosis (GO:0016079) | 3.15503665 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 3.15001912 |
| 40 | regulation of translational termination (GO:0006449) | 3.09663083 |
| 41 | establishment of apical/basal cell polarity (GO:0035089) | 3.08389331 |
| 42 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.05936001 |
| 43 | establishment of monopolar cell polarity (GO:0061162) | 3.05936001 |
| 44 | focal adhesion assembly (GO:0048041) | 3.05654179 |
| 45 | cell-substrate adherens junction assembly (GO:0007045) | 3.05654179 |
| 46 | mannose metabolic process (GO:0006013) | 3.05619581 |
| 47 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.04957361 |
| 48 | detection of external biotic stimulus (GO:0098581) | 3.04292953 |
| 49 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.02908122 |
| 50 | hypotonic response (GO:0006971) | 2.99164915 |
| 51 | positive regulation of synapse maturation (GO:0090129) | 2.98768462 |
| 52 | detection of molecule of bacterial origin (GO:0032490) | 2.98705331 |
| 53 | positive regulation of receptor recycling (GO:0001921) | 2.97991558 |
| 54 | glutamate secretion (GO:0014047) | 2.97689298 |
| 55 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.95296067 |
| 56 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.94983715 |
| 57 | adherens junction assembly (GO:0034333) | 2.93937083 |
| 58 | neuromuscular process controlling balance (GO:0050885) | 2.93928606 |
| 59 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.89517542 |
| 60 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.89517542 |
| 61 | regulation of leukocyte degranulation (GO:0043300) | 2.88652591 |
| 62 | cell-substrate junction assembly (GO:0007044) | 2.88631074 |
| 63 | response to laminar fluid shear stress (GO:0034616) | 2.88017545 |
| 64 | Golgi transport vesicle coating (GO:0048200) | 2.87482081 |
| 65 | COPI coating of Golgi vesicle (GO:0048205) | 2.87482081 |
| 66 | vocalization behavior (GO:0071625) | 2.86698558 |
| 67 | cellular potassium ion homeostasis (GO:0030007) | 2.85856161 |
| 68 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.84426753 |
| 69 | proline transport (GO:0015824) | 2.83535807 |
| 70 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.80863351 |
| 71 | neutrophil activation involved in immune response (GO:0002283) | 2.80306160 |
| 72 | neuronal action potential propagation (GO:0019227) | 2.79807901 |
| 73 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.79133017 |
| 74 | NADH metabolic process (GO:0006734) | 2.77468298 |
| 75 | leukocyte aggregation (GO:0070486) | 2.76305282 |
| 76 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.73802372 |
| 77 | macroautophagy (GO:0016236) | 2.71993397 |
| 78 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.70632298 |
| 79 | activation of Rac GTPase activity (GO:0032863) | 2.70174142 |
| 80 | cerebellar Purkinje cell layer development (GO:0021680) | 2.70116899 |
| 81 | response to muramyl dipeptide (GO:0032495) | 2.70022686 |
| 82 | dendritic spine morphogenesis (GO:0060997) | 2.69694913 |
| 83 | axon cargo transport (GO:0008088) | 2.68484648 |
| 84 | glycine transport (GO:0015816) | 2.68165286 |
| 85 | tricarboxylic acid cycle (GO:0006099) | 2.67374520 |
| 86 | positive regulation of sodium ion transport (GO:0010765) | 2.67343617 |
| 87 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.67033012 |
| 88 | modulation by symbiont of host cellular process (GO:0044068) | 2.66284584 |
| 89 | neuromuscular process controlling posture (GO:0050884) | 2.66104367 |
| 90 | establishment of nucleus localization (GO:0040023) | 2.65281148 |
| 91 | regulation of synapse structural plasticity (GO:0051823) | 2.64199972 |
| 92 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.63886343 |
| 93 | apoptotic process involved in morphogenesis (GO:0060561) | 2.63420123 |
| 94 | regulation of necroptotic process (GO:0060544) | 2.62609043 |
| 95 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.62451884 |
| 96 | signal complex assembly (GO:0007172) | 2.62398341 |
| 97 | neurotransmitter secretion (GO:0007269) | 2.61819529 |
| 98 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.61240404 |
| 99 | regulation of ARF protein signal transduction (GO:0032012) | 2.61154105 |
| 100 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.61067107 |
| 101 | detection of biotic stimulus (GO:0009595) | 2.60374673 |
| 102 | embryonic process involved in female pregnancy (GO:0060136) | 2.59869126 |
| 103 | skin morphogenesis (GO:0043589) | 2.59781645 |
| 104 | pinocytosis (GO:0006907) | 2.58423122 |
| 105 | cell junction maintenance (GO:0034331) | 2.58010267 |
| 106 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.56803901 |
| 107 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.56675101 |
| 108 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.55714559 |
| 109 | exploration behavior (GO:0035640) | 2.54884201 |
| 110 | cell-cell junction maintenance (GO:0045217) | 2.53496169 |
| 111 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.53345758 |
| 112 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.53239630 |
| 113 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.53122969 |
| 114 | detection of temperature stimulus (GO:0016048) | 2.52651274 |
| 115 | response to host (GO:0075136) | 2.52597742 |
| 116 | response to host defenses (GO:0052200) | 2.52597742 |
| 117 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.52597742 |
| 118 | regulation of synaptic vesicle transport (GO:1902803) | 2.52417056 |
| 119 | regulation of mast cell degranulation (GO:0043304) | 2.51886039 |
| 120 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.51578845 |
| 121 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.51385973 |
| 122 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.50347064 |
| 123 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.50332165 |
| 124 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.50152303 |
| 125 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.48981502 |
| 126 | organelle transport along microtubule (GO:0072384) | 2.48855743 |
| 127 | protein localization to endosome (GO:0036010) | 2.48113978 |
| 128 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.47703797 |
| 129 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.47605884 |
| 130 | cellular extravasation (GO:0045123) | 2.47351007 |
| 131 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.47170917 |
| 132 | germinal center formation (GO:0002467) | 2.46196258 |
| 133 | regulation of regulated secretory pathway (GO:1903305) | 2.45515755 |
| 134 | establishment of mitochondrion localization (GO:0051654) | 2.45407523 |
| 135 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.44760195 |
| 136 | cortical actin cytoskeleton organization (GO:0030866) | 2.44669108 |
| 137 | neuroblast proliferation (GO:0007405) | 2.44586262 |
| 138 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.44488340 |
| 139 | potassium ion import (GO:0010107) | 2.43353382 |
| 140 | vesicle transport along microtubule (GO:0047496) | 2.42603174 |
| 141 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.41948408 |
| 142 | mating behavior (GO:0007617) | 2.41533573 |
| 143 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.41436538 |
| 144 | negative regulation of type 2 immune response (GO:0002829) | 2.41403541 |
| 145 | modulation by virus of host process (GO:0019054) | 2.41358937 |
| 146 | negative regulation of necroptotic process (GO:0060546) | 2.40437392 |
| 147 | protein targeting to plasma membrane (GO:0072661) | 2.39910077 |
| 148 | regulation of macrophage cytokine production (GO:0010935) | 2.39803243 |
| 149 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.39731661 |
| 150 | response to host immune response (GO:0052572) | 2.39731661 |
| 151 | regulation of ARF GTPase activity (GO:0032312) | 2.38736350 |
| 152 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.38087418 |
| 153 | positive regulation of protein dephosphorylation (GO:0035307) | 2.37386538 |
| 154 | regulation of extracellular matrix disassembly (GO:0010715) | 2.37186104 |
| 155 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.36898838 |
| 156 | response to pheromone (GO:0019236) | 2.36781430 |
| 157 | alanine transport (GO:0032328) | 2.36053423 |
| 158 | regulation of early endosome to late endosome transport (GO:2000641) | 2.36001363 |
| 159 | membrane repolarization (GO:0086009) | 2.33693983 |
| 160 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.32945653 |
| 161 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.32628687 |
| 162 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.32343107 |
| 163 | basement membrane organization (GO:0071711) | 2.32287079 |
| 164 | regulation of defense response to virus by virus (GO:0050690) | 2.32050186 |
| 165 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.31708634 |
| 166 | sarcomere organization (GO:0045214) | 2.30800478 |
| 167 | regulation of necrotic cell death (GO:0010939) | 2.29912657 |
| 168 | membrane depolarization during action potential (GO:0086010) | 2.29561743 |
| 169 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.28711782 |
| 170 | thioester biosynthetic process (GO:0035384) | 2.28376133 |
| 171 | acyl-CoA biosynthetic process (GO:0071616) | 2.28376133 |
| 172 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.28316569 |
| 173 | regulation of autophagic vacuole assembly (GO:2000785) | 2.28131358 |
| 174 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.27914115 |
| 175 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.27147762 |
| 176 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.26864170 |
| 177 | ncRNA 3-end processing (GO:0043628) | 2.26525822 |
| 178 | mitochondrion transport along microtubule (GO:0047497) | 2.26355808 |
| 179 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.26355808 |
| 180 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.26000267 |
| 181 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.25366247 |
| 182 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.25069579 |
| 183 | maternal placenta development (GO:0001893) | 2.23831663 |
| 184 | negative regulation of myotube differentiation (GO:0010832) | 2.23167463 |
| 185 | negative regulation of fatty acid transport (GO:2000192) | 2.23134504 |
| 186 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.22201509 |
| 187 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.21723375 |
| 188 | regulation of gamma-delta T cell activation (GO:0046643) | 2.19612298 |
| 189 | cortical cytoskeleton organization (GO:0030865) | 2.19349600 |
| 190 | activation of JUN kinase activity (GO:0007257) | 2.18495982 |
| 191 | NIK/NF-kappaB signaling (GO:0038061) | 2.16357502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZNF263_19887448_ChIP-Seq_K562_Human | 4.30735011 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.96732622 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.86772119 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.79512986 |
| 5 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.66733652 |
| 6 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.61402060 |
| 7 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.58518452 |
| 8 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.54113843 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.47452675 |
| 10 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.40601557 |
| 11 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.38307037 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.34747081 |
| 13 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.32357785 |
| 14 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.26847278 |
| 15 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.20001822 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.06580561 |
| 17 | KDM2B_26808549_Chip-Seq_K562_Human | 2.06506969 |
| 18 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.00709916 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.97663479 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.97306990 |
| 21 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.91355793 |
| 22 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.88889828 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.84529771 |
| 24 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.83280489 |
| 25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.81665452 |
| 26 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.81403232 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.76438310 |
| 28 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.74508236 |
| 29 | * MAF_26560356_Chip-Seq_TH1_Human | 1.74482217 |
| 30 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73726008 |
| 31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.73399557 |
| 32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71805620 |
| 33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.70165811 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69515402 |
| 35 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.68676727 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68516768 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.66335946 |
| 38 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.66133322 |
| 39 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.65777644 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64800962 |
| 41 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.62017958 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.59069185 |
| 43 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.56200205 |
| 44 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.56200205 |
| 45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.55382327 |
| 46 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.54388962 |
| 47 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.52206248 |
| 48 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.52111279 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.50989768 |
| 50 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.50810917 |
| 51 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.50571459 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.50444008 |
| 53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50028121 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49926858 |
| 55 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.48609050 |
| 56 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.47962368 |
| 57 | P68_20966046_ChIP-Seq_HELA_Human | 1.47794182 |
| 58 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.46158945 |
| 59 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.45355939 |
| 60 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.44469979 |
| 61 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.43588802 |
| 62 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.43542558 |
| 63 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42675437 |
| 64 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.42607287 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41784421 |
| 66 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.40873754 |
| 67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.39612279 |
| 68 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.39309885 |
| 69 | ATF3_27146783_Chip-Seq_COLON_Human | 1.38534823 |
| 70 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.38426291 |
| 71 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.38014924 |
| 72 | * MAF_26560356_Chip-Seq_TH2_Human | 1.37386513 |
| 73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37376950 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.36099605 |
| 75 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.34356281 |
| 76 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.33922596 |
| 77 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31468523 |
| 78 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.31245836 |
| 79 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.31112294 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30938116 |
| 81 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.30548182 |
| 82 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.30303071 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29867420 |
| 84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.29109687 |
| 85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29036513 |
| 86 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28842274 |
| 87 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.28346519 |
| 88 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.27578761 |
| 89 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.27321530 |
| 90 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25875899 |
| 91 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.25831998 |
| 92 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.24974289 |
| 93 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.24710652 |
| 94 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.23318946 |
| 95 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23212117 |
| 96 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22693826 |
| 97 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.22564103 |
| 98 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21821612 |
| 99 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.21600294 |
| 100 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.21577278 |
| 101 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.21223540 |
| 102 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.20093181 |
| 103 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18988394 |
| 104 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.18528356 |
| 105 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.18501776 |
| 106 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17827059 |
| 107 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.17274248 |
| 108 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.17090736 |
| 109 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.16880005 |
| 110 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.16577827 |
| 111 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.14685731 |
| 112 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13639100 |
| 113 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.11483699 |
| 114 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.11302894 |
| 115 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.10739656 |
| 116 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.10291022 |
| 117 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09971856 |
| 118 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.09526022 |
| 119 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.09081375 |
| 120 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.08758716 |
| 121 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.07426261 |
| 122 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07110170 |
| 123 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.06613473 |
| 124 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.06116624 |
| 125 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.04644003 |
| 126 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04573162 |
| 127 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04480530 |
| 128 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.04447017 |
| 129 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.03939334 |
| 130 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.03776083 |
| 131 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02408892 |
| 132 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.01817151 |
| 133 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.01552641 |
| 134 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01389577 |
| 135 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.00652212 |
| 136 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00482632 |
| 137 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00286601 |
| 138 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.00112216 |
| 139 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.00112216 |
| 140 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.00038487 |
| 141 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.99697976 |
| 142 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99538998 |
| 143 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99487205 |
| 144 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99108496 |
| 145 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.99006340 |
| 146 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98398582 |
| 147 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98271291 |
| 148 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.96456889 |
| 149 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.96218058 |
| 150 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95474594 |
| 151 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94220652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 3.63042214 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.59700833 |
| 3 | MP0005451_abnormal_body_composition | 3.17858373 |
| 4 | MP0003436_decreased_susceptibility_to | 2.95096840 |
| 5 | MP0004270_analgesia | 2.92504615 |
| 6 | MP0004858_abnormal_nervous_system | 2.89915234 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.87068454 |
| 8 | MP0003303_peritoneal_inflammation | 2.80770030 |
| 9 | MP0003566_abnormal_cell_adhesion | 2.78015663 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 2.71550478 |
| 11 | MP0008260_abnormal_autophagy | 2.71177957 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.68032151 |
| 13 | MP0000751_myopathy | 2.63701137 |
| 14 | MP0000013_abnormal_adipose_tissue | 2.50391222 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.45015584 |
| 16 | MP0008961_abnormal_basal_metabolism | 2.43777800 |
| 17 | MP0003329_amyloid_beta_deposits | 2.34370950 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.30414745 |
| 19 | MP0003635_abnormal_synaptic_transmissio | 2.23869969 |
| 20 | MP0003091_abnormal_cell_migration | 2.16554500 |
| 21 | MP0004130_abnormal_muscle_cell | 2.08969799 |
| 22 | MP0000747_muscle_weakness | 2.07089784 |
| 23 | MP0001958_emphysema | 2.01551436 |
| 24 | MP0002909_abnormal_adrenal_gland | 1.99846748 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.97064663 |
| 26 | MP0004084_abnormal_cardiac_muscle | 1.94898872 |
| 27 | MP0003724_increased_susceptibility_to | 1.92840675 |
| 28 | MP0004233_abnormal_muscle_weight | 1.89318311 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.85825049 |
| 30 | MP0005076_abnormal_cell_differentiation | 1.81793184 |
| 31 | MP0004947_skin_inflammation | 1.81599891 |
| 32 | MP0009278_abnormal_bone_marrow | 1.81373919 |
| 33 | MP0005409_darkened_coat_color | 1.81037707 |
| 34 | MP0003828_pulmonary_edema | 1.80175750 |
| 35 | MP0002735_abnormal_chemical_nociception | 1.77818317 |
| 36 | MP0002419_abnormal_innate_immunity | 1.77036932 |
| 37 | MP0003283_abnormal_digestive_organ | 1.76204996 |
| 38 | MP0000858_altered_metastatic_potential | 1.75040025 |
| 39 | MP0002064_seizures | 1.72971063 |
| 40 | MP0009046_muscle_twitch | 1.70499163 |
| 41 | MP0004185_abnormal_adipocyte_glucose | 1.70403040 |
| 42 | MP0003279_aneurysm | 1.70302474 |
| 43 | MP0002734_abnormal_mechanical_nocicepti | 1.69913678 |
| 44 | MP0002733_abnormal_thermal_nociception | 1.66390549 |
| 45 | MP0004885_abnormal_endolymph | 1.65837192 |
| 46 | MP0002269_muscular_atrophy | 1.64924742 |
| 47 | MP0002653_abnormal_ependyma_morphology | 1.61135711 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.59995273 |
| 49 | MP0003453_abnormal_keratinocyte_physiol | 1.59586283 |
| 50 | MP0004087_abnormal_muscle_fiber | 1.58582808 |
| 51 | MP0000003_abnormal_adipose_tissue | 1.57237941 |
| 52 | MP0002063_abnormal_learning/memory/cond | 1.56524710 |
| 53 | MP0004147_increased_porphyrin_level | 1.55205658 |
| 54 | MP0004215_abnormal_myocardial_fiber | 1.54741197 |
| 55 | MP0004510_myositis | 1.54190557 |
| 56 | MP0004811_abnormal_neuron_physiology | 1.52306797 |
| 57 | MP0005025_abnormal_response_to | 1.52068044 |
| 58 | MP0000685_abnormal_immune_system | 1.51103400 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.50276043 |
| 60 | MP0001968_abnormal_touch/_nociception | 1.50258429 |
| 61 | MP0000749_muscle_degeneration | 1.49401034 |
| 62 | MP0003646_muscle_fatigue | 1.47933396 |
| 63 | MP0005623_abnormal_meninges_morphology | 1.47764097 |
| 64 | MP0009840_abnormal_foam_cell | 1.46536049 |
| 65 | MP0004036_abnormal_muscle_relaxation | 1.46300817 |
| 66 | MP0002272_abnormal_nervous_system | 1.46009828 |
| 67 | MP0005083_abnormal_biliary_tract | 1.45919927 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.42534322 |
| 69 | MP0001970_abnormal_pain_threshold | 1.41067221 |
| 70 | MP0003221_abnormal_cardiomyocyte_apopto | 1.38249772 |
| 71 | MP0001835_abnormal_antigen_presentation | 1.37465184 |
| 72 | MP0000955_abnormal_spinal_cord | 1.35991338 |
| 73 | MP0003183_abnormal_peptide_metabolism | 1.35880237 |
| 74 | MP0005330_cardiomyopathy | 1.34253526 |
| 75 | MP0005023_abnormal_wound_healing | 1.33321324 |
| 76 | MP0003137_abnormal_impulse_conducting | 1.33213296 |
| 77 | MP0005257_abnormal_intraocular_pressure | 1.31387801 |
| 78 | MP0005375_adipose_tissue_phenotype | 1.30390442 |
| 79 | MP0000759_abnormal_skeletal_muscle | 1.29189727 |
| 80 | MP0005000_abnormal_immune_tolerance | 1.28203900 |
| 81 | MP0004043_abnormal_pH_regulation | 1.27733886 |
| 82 | MP0009745_abnormal_behavioral_response | 1.24548472 |
| 83 | MP0001440_abnormal_grooming_behavior | 1.22649255 |
| 84 | MP0003634_abnormal_glial_cell | 1.22044475 |
| 85 | MP0008569_lethality_at_weaning | 1.20977298 |
| 86 | MP0001790_abnormal_immune_system | 1.20971634 |
| 87 | MP0005387_immune_system_phenotype | 1.20971634 |
| 88 | MP0010234_abnormal_vibrissa_follicle | 1.19292208 |
| 89 | MP0005666_abnormal_adipose_tissue | 1.18728988 |
| 90 | MP0001849_ear_inflammation | 1.16765829 |
| 91 | MP0004145_abnormal_muscle_electrophysio | 1.15538108 |
| 92 | MP0003075_altered_response_to | 1.14404598 |
| 93 | MP0002420_abnormal_adaptive_immunity | 1.13793753 |
| 94 | MP0001819_abnormal_immune_cell | 1.13116291 |
| 95 | MP0003763_abnormal_thymus_physiology | 1.11454698 |
| 96 | MP0002972_abnormal_cardiac_muscle | 1.11296659 |
| 97 | MP0000767_abnormal_smooth_muscle | 1.10860158 |
| 98 | MP0002067_abnormal_sensory_capabilities | 1.09174522 |
| 99 | MP0002736_abnormal_nociception_after | 1.07865657 |
| 100 | MP0006082_CNS_inflammation | 1.06949220 |
| 101 | MP0002452_abnormal_antigen_presenting | 1.06859578 |
| 102 | MP0002723_abnormal_immune_serum | 1.06557907 |
| 103 | MP0010155_abnormal_intestine_physiology | 1.06185582 |
| 104 | MP0002234_abnormal_pharynx_morphology | 1.06143613 |
| 105 | MP0009785_altered_susceptibility_to | 1.06076306 |
| 106 | MP0009333_abnormal_splenocyte_physiolog | 1.05936428 |
| 107 | MP0005620_abnormal_muscle_contractility | 1.05582017 |
| 108 | MP0004085_abnormal_heartbeat | 1.04858162 |
| 109 | MP0002184_abnormal_innervation | 1.04346270 |
| 110 | MP0002066_abnormal_motor_capabilities/c | 1.04281949 |
| 111 | MP0008775_abnormal_heart_ventricle | 1.04273865 |
| 112 | MP0001800_abnormal_humoral_immune | 1.03123941 |
| 113 | MP0003448_altered_tumor_morphology | 1.03091833 |
| 114 | MP0002877_abnormal_melanocyte_morpholog | 1.02789947 |
| 115 | MP0002572_abnormal_emotion/affect_behav | 1.02410174 |
| 116 | MP0002060_abnormal_skin_morphology | 1.01830058 |
| 117 | MP0000750_abnormal_muscle_regeneration | 1.01396321 |
| 118 | MP0010352_gastrointestinal_tract_polyps | 1.01371750 |
| 119 | MP0002396_abnormal_hematopoietic_system | 1.01149866 |
| 120 | MP0002882_abnormal_neuron_morphology | 0.98726362 |
| 121 | MP0000604_amyloidosis | 0.96349513 |
| 122 | MP0001348_abnormal_lacrimal_gland | 0.95695515 |
| 123 | MP0000678_abnormal_parathyroid_gland | 0.95657409 |
| 124 | MP0006138_congestive_heart_failure | 0.95290403 |
| 125 | MP0001851_eye_inflammation | 0.95272588 |
| 126 | MP0003879_abnormal_hair_cell | 0.94836705 |
| 127 | MP0002106_abnormal_muscle_physiology | 0.94033854 |
| 128 | MP0002405_respiratory_system_inflammati | 0.93195078 |
| 129 | MP0001486_abnormal_startle_reflex | 0.93075753 |
| 130 | MP0004808_abnormal_hematopoietic_stem | 0.93032278 |
| 131 | MP0005621_abnormal_cell_physiology | 0.92236043 |
| 132 | MP0002398_abnormal_bone_marrow | 0.91630730 |
| 133 | MP0003690_abnormal_glial_cell | 0.90793437 |
| 134 | MP0005275_abnormal_skin_tensile | 0.90286029 |
| 135 | MP0002796_impaired_skin_barrier | 0.89706616 |
| 136 | MP0010630_abnormal_cardiac_muscle | 0.89522091 |
| 137 | MP0001299_abnormal_eye_distance/ | 0.89175446 |
| 138 | MP0001915_intracranial_hemorrhage | 0.89002896 |
| 139 | MP0002089_abnormal_postnatal_growth/wei | 0.88868753 |
| 140 | MP0004381_abnormal_hair_follicle | 0.87409743 |
| 141 | MP0005390_skeleton_phenotype | 0.86380293 |
| 142 | MP0000778_abnormal_nervous_system | 0.86295835 |
| 143 | MP0000343_altered_response_to | 0.85888281 |
| 144 | MP0004142_abnormal_muscle_tone | 0.84872610 |
| 145 | MP0000716_abnormal_immune_system | 0.84699675 |
| 146 | MP0002229_neurodegeneration | 0.83778750 |
| 147 | MP0000537_abnormal_urethra_morphology | 0.83626467 |
| 148 | MP0001544_abnormal_cardiovascular_syste | 0.83295892 |
| 149 | MP0005385_cardiovascular_system_phenoty | 0.83295892 |
| 150 | MP0005386_behavior/neurological_phenoty | 0.83123671 |
| 151 | MP0004924_abnormal_behavior | 0.83123671 |
| 152 | MP0002152_abnormal_brain_morphology | 0.82674513 |
| 153 | MP0001545_abnormal_hematopoietic_system | 0.82605106 |
| 154 | MP0005397_hematopoietic_system_phenotyp | 0.82605106 |
| 155 | MP0003633_abnormal_nervous_system | 0.82382388 |
| 156 | MP0005501_abnormal_skin_physiology | 0.81652656 |
| 157 | MP0002896_abnormal_bone_mineralization | 0.81438504 |
| 158 | MP0006276_abnormal_autonomic_nervous | 0.81076194 |
| 159 | MP0000733_abnormal_muscle_development | 0.80670750 |
| 160 | MP0006072_abnormal_retinal_apoptosis | 0.79733622 |
| 161 | MP0004484_altered_response_of | 0.79194851 |
| 162 | MP0008874_decreased_physiological_sensi | 0.78223534 |
| 163 | MP0005164_abnormal_response_to | 0.76507258 |
| 164 | MP0003632_abnormal_nervous_system | 0.76463138 |
| 165 | MP0001845_abnormal_inflammatory_respons | 0.75551222 |
| 166 | MP0005423_abnormal_somatic_nervous | 0.75084778 |
| 167 | MP0003656_abnormal_erythrocyte_physiolo | 0.73082127 |
| 168 | MP0003631_nervous_system_phenotype | 0.72848326 |
| 169 | MP0005369_muscle_phenotype | 0.72086184 |
| 170 | MP0000920_abnormal_myelination | 0.71707531 |
| 171 | MP0004272_abnormal_basement_membrane | 0.70066904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 3.93499154 |
| 2 | Eczematoid dermatitis (HP:0000976) | 3.74822477 |
| 3 | Termporal pattern (HP:0011008) | 3.46855535 |
| 4 | Insidious onset (HP:0003587) | 3.46855535 |
| 5 | Protrusio acetabuli (HP:0003179) | 3.41017838 |
| 6 | Hyporeflexia of lower limbs (HP:0002600) | 3.33413152 |
| 7 | Pheochromocytoma (HP:0002666) | 3.32228566 |
| 8 | Premature rupture of membranes (HP:0001788) | 3.29666613 |
| 9 | Abnormality of the lower motor neuron (HP:0002366) | 3.15540562 |
| 10 | Visual hallucinations (HP:0002367) | 2.99310926 |
| 11 | Action tremor (HP:0002345) | 2.91975253 |
| 12 | Insomnia (HP:0100785) | 2.91104607 |
| 13 | Sudden death (HP:0001699) | 2.86734449 |
| 14 | Bundle branch block (HP:0011710) | 2.86372003 |
| 15 | Ventricular fibrillation (HP:0001663) | 2.84159572 |
| 16 | Myotonia (HP:0002486) | 2.79112184 |
| 17 | Supranuclear gaze palsy (HP:0000605) | 2.73893257 |
| 18 | Distal lower limb amyotrophy (HP:0008944) | 2.73583256 |
| 19 | Abnormality of macrophages (HP:0004311) | 2.72536001 |
| 20 | Neuroendocrine neoplasm (HP:0100634) | 2.70441343 |
| 21 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.68073585 |
| 22 | Distal lower limb muscle weakness (HP:0009053) | 2.66757416 |
| 23 | Difficulty running (HP:0009046) | 2.65931359 |
| 24 | Recurrent abscess formation (HP:0002722) | 2.65519721 |
| 25 | Resting tremor (HP:0002322) | 2.63689461 |
| 26 | Cellulitis (HP:0100658) | 2.60589127 |
| 27 | Ankle clonus (HP:0011448) | 2.60013505 |
| 28 | Rapidly progressive (HP:0003678) | 2.59310015 |
| 29 | Abnormality of the corticospinal tract (HP:0002492) | 2.56051347 |
| 30 | Vertebral compression fractures (HP:0002953) | 2.52491896 |
| 31 | Urinary urgency (HP:0000012) | 2.51944895 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 2.51220151 |
| 33 | Hamartoma of the eye (HP:0010568) | 2.48755655 |
| 34 | Peritonitis (HP:0002586) | 2.47711908 |
| 35 | Hypercortisolism (HP:0001578) | 2.47521170 |
| 36 | Upper limb amyotrophy (HP:0009129) | 2.46572539 |
| 37 | Distal upper limb amyotrophy (HP:0007149) | 2.46572539 |
| 38 | Obstructive sleep apnea (HP:0002870) | 2.46085221 |
| 39 | Focal seizures (HP:0007359) | 2.41877838 |
| 40 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.41632026 |
| 41 | Depression (HP:0000716) | 2.40806810 |
| 42 | Neoplasm of the heart (HP:0100544) | 2.39768404 |
| 43 | Achilles tendon contracture (HP:0001771) | 2.38701351 |
| 44 | Gingivitis (HP:0000230) | 2.32183908 |
| 45 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.31967713 |
| 46 | Broad face (HP:0000283) | 2.31798457 |
| 47 | Type 1 muscle fiber predominance (HP:0003803) | 2.31073228 |
| 48 | Dilatation of the ascending aorta (HP:0005111) | 2.30731425 |
| 49 | Global brain atrophy (HP:0002283) | 2.30020014 |
| 50 | Abnormality of the Achilles tendon (HP:0005109) | 2.28055720 |
| 51 | Exercise-induced myalgia (HP:0003738) | 2.27759352 |
| 52 | Muscle fiber splitting (HP:0003555) | 2.27374150 |
| 53 | Difficulty climbing stairs (HP:0003551) | 2.26344057 |
| 54 | Hand muscle atrophy (HP:0009130) | 2.25635499 |
| 55 | Cerebral inclusion bodies (HP:0100314) | 2.23251564 |
| 56 | Arterial tortuosity (HP:0005116) | 2.20593636 |
| 57 | Focal motor seizures (HP:0011153) | 2.18772203 |
| 58 | Fragile skin (HP:0001030) | 2.17791238 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.15653884 |
| 60 | Myoglobinuria (HP:0002913) | 2.15524886 |
| 61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.15268542 |
| 62 | Genu recurvatum (HP:0002816) | 2.14541032 |
| 63 | EMG: neuropathic changes (HP:0003445) | 2.14418740 |
| 64 | Vascular tortuosity (HP:0004948) | 2.13965433 |
| 65 | Spastic gait (HP:0002064) | 2.13788917 |
| 66 | Disproportionate tall stature (HP:0001519) | 2.13078370 |
| 67 | Hammertoe (HP:0001765) | 2.09922360 |
| 68 | Cervical subluxation (HP:0003308) | 2.09238816 |
| 69 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.09010215 |
| 70 | Lower limb amyotrophy (HP:0007210) | 2.07891518 |
| 71 | Spinal rigidity (HP:0003306) | 2.07041053 |
| 72 | Progressive sensorineural hearing impairment (HP:0000408) | 2.05722509 |
| 73 | Atrophic scars (HP:0001075) | 2.05566919 |
| 74 | Increased connective tissue (HP:0009025) | 2.05554945 |
| 75 | Dysmetric saccades (HP:0000641) | 2.05384386 |
| 76 | Increased IgE level (HP:0003212) | 2.05170677 |
| 77 | Cholelithiasis (HP:0001081) | 2.04355178 |
| 78 | Adenoma sebaceum (HP:0009720) | 2.02873287 |
| 79 | Angiofibromas (HP:0010615) | 2.02873287 |
| 80 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.02817093 |
| 81 | Myositis (HP:0100614) | 2.02579128 |
| 82 | Ulnar bowing (HP:0003031) | 2.02404490 |
| 83 | Impaired social interactions (HP:0000735) | 2.00546889 |
| 84 | Abnormal social behavior (HP:0012433) | 2.00546889 |
| 85 | Blue sclerae (HP:0000592) | 2.00443786 |
| 86 | Aneurysm (HP:0002617) | 2.00176134 |
| 87 | Back pain (HP:0003418) | 1.98841932 |
| 88 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.98646127 |
| 89 | Athetosis (HP:0002305) | 1.98199309 |
| 90 | Mitral regurgitation (HP:0001653) | 1.97326892 |
| 91 | Thin bony cortex (HP:0002753) | 1.96996765 |
| 92 | Polycythemia (HP:0001901) | 1.96008255 |
| 93 | Atonic seizures (HP:0010819) | 1.95596898 |
| 94 | Flat acetabular roof (HP:0003180) | 1.95586810 |
| 95 | Lymphangioma (HP:0100764) | 1.95310489 |
| 96 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.94511320 |
| 97 | Turricephaly (HP:0000262) | 1.93940351 |
| 98 | Hemiplegia (HP:0002301) | 1.93817930 |
| 99 | Aortic aneurysm (HP:0004942) | 1.93783025 |
| 100 | Lower limb muscle weakness (HP:0007340) | 1.91940457 |
| 101 | Obstructive lung disease (HP:0006536) | 1.91664145 |
| 102 | Chronic obstructive pulmonary disease (HP:0006510) | 1.91664145 |
| 103 | Gastrointestinal infarctions (HP:0005244) | 1.90190300 |
| 104 | Increased variability in muscle fiber diameter (HP:0003557) | 1.89924226 |
| 105 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.89494785 |
| 106 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.89494785 |
| 107 | Megalencephaly (HP:0001355) | 1.89088859 |
| 108 | Diaphragmatic weakness (HP:0009113) | 1.88791396 |
| 109 | Orchitis (HP:0100796) | 1.88542531 |
| 110 | Cerebral aneurysm (HP:0004944) | 1.88522784 |
| 111 | Atrioventricular block (HP:0001678) | 1.88375795 |
| 112 | Ventricular tachycardia (HP:0004756) | 1.87583123 |
| 113 | Right ventricular cardiomyopathy (HP:0011663) | 1.86797174 |
| 114 | Ketoacidosis (HP:0001993) | 1.86177499 |
| 115 | Exercise-induced muscle cramps (HP:0003710) | 1.85726487 |
| 116 | Ulnar claw (HP:0001178) | 1.85579040 |
| 117 | Neurofibrillary tangles (HP:0002185) | 1.85052351 |
| 118 | Conjunctival hamartoma (HP:0100780) | 1.84953426 |
| 119 | Heart block (HP:0012722) | 1.84841568 |
| 120 | Foot dorsiflexor weakness (HP:0009027) | 1.84497348 |
| 121 | Metaphyseal cupping (HP:0003021) | 1.83472600 |
| 122 | Shallow orbits (HP:0000586) | 1.82671285 |
| 123 | Abnormal gallbladder morphology (HP:0012437) | 1.82252508 |
| 124 | Reticulocytosis (HP:0001923) | 1.81742147 |
| 125 | Intention tremor (HP:0002080) | 1.81373078 |
| 126 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.81265515 |
| 127 | Impaired pain sensation (HP:0007328) | 1.80587667 |
| 128 | Abnormality of pain sensation (HP:0010832) | 1.80587667 |
| 129 | Wormian bones (HP:0002645) | 1.79565831 |
| 130 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.79408331 |
| 131 | Osteolytic defects of the hand bones (HP:0009699) | 1.79408331 |
| 132 | Abnormal gallbladder physiology (HP:0012438) | 1.79244260 |
| 133 | Cholecystitis (HP:0001082) | 1.79244260 |
| 134 | Gout (HP:0001997) | 1.79042599 |
| 135 | Aortic dissection (HP:0002647) | 1.78318353 |
| 136 | Anxiety (HP:0000739) | 1.76945220 |
| 137 | Hemorrhage of the eye (HP:0011885) | 1.76578095 |
| 138 | Syringomyelia (HP:0003396) | 1.76296608 |
| 139 | Spinal cord lesions (HP:0100561) | 1.76296608 |
| 140 | Postural instability (HP:0002172) | 1.75949440 |
| 141 | Syncope (HP:0001279) | 1.75598280 |
| 142 | Abnormality of the foot musculature (HP:0001436) | 1.75462986 |
| 143 | Absence seizures (HP:0002121) | 1.75193800 |
| 144 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.75153810 |
| 145 | Fibroma (HP:0010614) | 1.74940846 |
| 146 | Ankle contracture (HP:0006466) | 1.74527795 |
| 147 | Pointed chin (HP:0000307) | 1.73913014 |
| 148 | Mitral valve prolapse (HP:0001634) | 1.73397528 |
| 149 | Slender build (HP:0001533) | 1.73286123 |
| 150 | Asymmetric septal hypertrophy (HP:0001670) | 1.72944956 |
| 151 | Amyloidosis (HP:0011034) | 1.72757954 |
| 152 | Long palpebral fissure (HP:0000637) | 1.72650390 |
| 153 | Abnormal atrioventricular conduction (HP:0005150) | 1.72445832 |
| 154 | Myopathic facies (HP:0002058) | 1.70668119 |
| 155 | Onion bulb formation (HP:0003383) | 1.69985748 |
| 156 | Distal sensory impairment (HP:0002936) | 1.69442990 |
| 157 | Polygenic inheritance (HP:0010982) | 1.69426116 |
| 158 | Abnormal platelet volume (HP:0011876) | 1.69354600 |
| 159 | Interstitial pulmonary disease (HP:0006530) | 1.68920783 |
| 160 | Poor eye contact (HP:0000817) | 1.68662845 |
| 161 | Slow saccadic eye movements (HP:0000514) | 1.68507999 |
| 162 | Short nail (HP:0001799) | 1.68121347 |
| 163 | Mediastinal lymphadenopathy (HP:0100721) | 1.67748699 |
| 164 | Dysostosis multiplex (HP:0000943) | 1.67048853 |
| 165 | Ventricular arrhythmia (HP:0004308) | 1.67023092 |
| 166 | EMG: myopathic abnormalities (HP:0003458) | 1.67006478 |
| 167 | Ankyloglossia (HP:0010296) | 1.65803282 |
| 168 | Subacute progressive viral hepatitis (HP:0006572) | 1.65415456 |
| 169 | Increased cerebral lipofuscin (HP:0011813) | 1.65204958 |
| 170 | Skin nodule (HP:0200036) | 1.64725093 |
| 171 | Hyperacusis (HP:0010780) | 1.64473883 |
| 172 | Bladder diverticulum (HP:0000015) | 1.63063826 |
| 173 | Decreased motor nerve conduction velocity (HP:0003431) | 1.59281357 |
| 174 | Abnormality of the peritoneum (HP:0002585) | 1.58728771 |
| 175 | Biconcave vertebral bodies (HP:0004586) | 1.58513280 |
| 176 | Urticaria (HP:0001025) | 1.58507820 |
| 177 | Abnormality of the nasal mucosa (HP:0000433) | 1.57878975 |
| 178 | Upper motor neuron abnormality (HP:0002127) | 1.57435044 |
| 179 | Emphysema (HP:0002097) | 1.56202316 |
| 180 | Joint laxity (HP:0001388) | 1.55847902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.86119082 |
| 2 | PRPF4B | 3.44572253 |
| 3 | MAP2K3 | 2.60057717 |
| 4 | MAP3K9 | 2.56423528 |
| 5 | SMG1 | 2.50482285 |
| 6 | RIPK4 | 2.40300358 |
| 7 | NTRK1 | 2.37925144 |
| 8 | KSR2 | 2.34024614 |
| 9 | PKN2 | 2.28473878 |
| 10 | LATS2 | 2.28330570 |
| 11 | PAK6 | 2.20591172 |
| 12 | TTN | 1.98911836 |
| 13 | MAP3K4 | 1.98671189 |
| 14 | MINK1 | 1.97947015 |
| 15 | LMTK2 | 1.92530324 |
| 16 | RIPK1 | 1.91907366 |
| 17 | MAP2K4 | 1.87139421 |
| 18 | EEF2K | 1.84479715 |
| 19 | MAP3K10 | 1.72085640 |
| 20 | MAP3K13 | 1.70181751 |
| 21 | EPHB1 | 1.65790972 |
| 22 | MAP3K3 | 1.64278532 |
| 23 | RET | 1.63440190 |
| 24 | IRAK3 | 1.58536653 |
| 25 | CDK12 | 1.57485408 |
| 26 | PHKG1 | 1.52969919 |
| 27 | PHKG2 | 1.52969919 |
| 28 | NEK1 | 1.51163478 |
| 29 | NTRK3 | 1.46705385 |
| 30 | MAPKAPK3 | 1.44764352 |
| 31 | IRAK4 | 1.44750714 |
| 32 | PDGFRA | 1.44401943 |
| 33 | ZAP70 | 1.42513495 |
| 34 | ALK | 1.39980377 |
| 35 | TAOK2 | 1.39179639 |
| 36 | MAP3K2 | 1.39125637 |
| 37 | PRKD3 | 1.38077429 |
| 38 | PAK3 | 1.37490950 |
| 39 | MARK1 | 1.34157492 |
| 40 | TYK2 | 1.33018064 |
| 41 | PRKD2 | 1.32563716 |
| 42 | MAP4K1 | 1.32037257 |
| 43 | UHMK1 | 1.31948841 |
| 44 | BLK | 1.28459542 |
| 45 | CSK | 1.27327913 |
| 46 | TYRO3 | 1.26809798 |
| 47 | LIMK1 | 1.24624470 |
| 48 | MAP3K11 | 1.23069386 |
| 49 | STK38 | 1.22077976 |
| 50 | BCKDK | 1.21563902 |
| 51 | PAK4 | 1.17553566 |
| 52 | SCYL2 | 1.15422151 |
| 53 | MAP3K6 | 1.10763442 |
| 54 | ICK | 1.10580367 |
| 55 | DAPK2 | 1.09701534 |
| 56 | TAOK1 | 1.09470719 |
| 57 | EPHA2 | 1.06324636 |
| 58 | MARK2 | 1.05184739 |
| 59 | SIK1 | 1.04434506 |
| 60 | CAMKK1 | 1.04016362 |
| 61 | PTK2 | 1.03850406 |
| 62 | ARAF | 1.01199169 |
| 63 | CDK5 | 0.99512246 |
| 64 | WNK1 | 0.98496516 |
| 65 | PDK3 | 0.96840093 |
| 66 | PDK4 | 0.96840093 |
| 67 | WNK4 | 0.96680732 |
| 68 | FES | 0.94571187 |
| 69 | FER | 0.92795540 |
| 70 | CDK14 | 0.92642834 |
| 71 | JAK3 | 0.92255256 |
| 72 | FGFR2 | 0.91350418 |
| 73 | MAP3K14 | 0.91330764 |
| 74 | GRK6 | 0.91255069 |
| 75 | CDK15 | 0.86738816 |
| 76 | NTRK2 | 0.86736906 |
| 77 | MTOR | 0.85094793 |
| 78 | MAP3K1 | 0.84760477 |
| 79 | KSR1 | 0.84013516 |
| 80 | HCK | 0.83985761 |
| 81 | TBK1 | 0.83542685 |
| 82 | MAP2K1 | 0.83006428 |
| 83 | MOS | 0.82915725 |
| 84 | CDK18 | 0.82474814 |
| 85 | FGR | 0.80934783 |
| 86 | MAP3K7 | 0.80627468 |
| 87 | RPS6KA2 | 0.80614456 |
| 88 | CDK11A | 0.77768029 |
| 89 | GRK5 | 0.77128320 |
| 90 | TESK2 | 0.75715964 |
| 91 | IRAK2 | 0.74009523 |
| 92 | TESK1 | 0.73965092 |
| 93 | FGFR1 | 0.73046319 |
| 94 | BTK | 0.72110605 |
| 95 | TNK2 | 0.70886224 |
| 96 | BRSK1 | 0.70837148 |
| 97 | MET | 0.70683613 |
| 98 | BMX | 0.70366265 |
| 99 | PAK2 | 0.69932741 |
| 100 | PRKCH | 0.69172193 |
| 101 | PDK1 | 0.68686647 |
| 102 | JAK1 | 0.68471158 |
| 103 | SIK3 | 0.68338519 |
| 104 | PRKG2 | 0.68297409 |
| 105 | RPS6KC1 | 0.66785294 |
| 106 | RPS6KL1 | 0.66785294 |
| 107 | CDC42BPA | 0.66458336 |
| 108 | MAP3K8 | 0.65830769 |
| 109 | PTK6 | 0.64772666 |
| 110 | SGK3 | 0.64591223 |
| 111 | PRKD1 | 0.63655877 |
| 112 | DMPK | 0.63614183 |
| 113 | PRKAA1 | 0.63080714 |
| 114 | ERN1 | 0.62350606 |
| 115 | JAK2 | 0.61555941 |
| 116 | TGFBR2 | 0.61247878 |
| 117 | ERBB2 | 0.59091507 |
| 118 | CAMK1G | 0.57922536 |
| 119 | LRRK2 | 0.57134780 |
| 120 | STK11 | 0.55922134 |
| 121 | MST1R | 0.55397775 |
| 122 | MAP2K7 | 0.53169765 |
| 123 | PDPK1 | 0.53101461 |
| 124 | RAF1 | 0.52904508 |
| 125 | EPHB2 | 0.51879327 |
| 126 | ILK | 0.51751807 |
| 127 | DDR2 | 0.51291456 |
| 128 | CAMKK2 | 0.50906229 |
| 129 | DYRK1B | 0.48802706 |
| 130 | PNCK | 0.48199731 |
| 131 | MAP2K2 | 0.47991045 |
| 132 | FGFR4 | 0.47781080 |
| 133 | NEK9 | 0.46007059 |
| 134 | SIK2 | 0.45802532 |
| 135 | BRAF | 0.45078820 |
| 136 | MAPK12 | 0.44964392 |
| 137 | CSF1R | 0.43915275 |
| 138 | MAPK7 | 0.43767420 |
| 139 | CDK19 | 0.43601684 |
| 140 | ROCK1 | 0.43308739 |
| 141 | MAPK11 | 0.43292488 |
| 142 | PTK2B | 0.43245230 |
| 143 | PDGFRB | 0.43241258 |
| 144 | ROCK2 | 0.42989991 |
| 145 | FGFR3 | 0.42791888 |
| 146 | RPS6KA6 | 0.42708671 |
| 147 | HIPK2 | 0.40916762 |
| 148 | SGK494 | 0.40379926 |
| 149 | SGK223 | 0.40379926 |
| 150 | YES1 | 0.39636921 |
| 151 | DAPK3 | 0.39477063 |
| 152 | STK39 | 0.39366987 |
| 153 | FYN | 0.39333053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.84825296 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.49745657 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.48066646 |
| 4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.42987541 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.40484223 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.90360934 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.87012418 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.83776551 |
| 9 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.83675255 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.83667120 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.82551148 |
| 12 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.80895894 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.80776796 |
| 14 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.77356441 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.71985110 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68548373 |
| 17 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.53066952 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.50432604 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.45445802 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.44277494 |
| 21 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.43642645 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.41049196 |
| 23 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.39533295 |
| 24 | GABAergic synapse_Homo sapiens_hsa04727 | 1.36797712 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.36607497 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.34753782 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.34286475 |
| 28 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.34286403 |
| 29 | Long-term potentiation_Homo sapiens_hsa04720 | 1.33658092 |
| 30 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.32264007 |
| 31 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.31480356 |
| 32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.29147766 |
| 33 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.26960334 |
| 34 | Focal adhesion_Homo sapiens_hsa04510 | 1.26671280 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.23661908 |
| 36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.23315855 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23294052 |
| 38 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.23177793 |
| 39 | Amoebiasis_Homo sapiens_hsa05146 | 1.22498537 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.21203254 |
| 41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.19308163 |
| 42 | Circadian entrainment_Homo sapiens_hsa04713 | 1.18582254 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 1.18469770 |
| 44 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.18135288 |
| 45 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.17618795 |
| 46 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.16481294 |
| 47 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.16213437 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.14975442 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.11059117 |
| 50 | Malaria_Homo sapiens_hsa05144 | 1.10899117 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10758306 |
| 52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.09896865 |
| 53 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.09872545 |
| 54 | Nicotine addiction_Homo sapiens_hsa05033 | 1.09366653 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 1.08829799 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07967042 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.07925599 |
| 58 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.07752780 |
| 59 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.07504390 |
| 60 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.07063311 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 1.06262536 |
| 62 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05746293 |
| 63 | Shigellosis_Homo sapiens_hsa05131 | 1.05248526 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.04925367 |
| 65 | Salivary secretion_Homo sapiens_hsa04970 | 1.04235549 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.03525836 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03503126 |
| 68 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.03459458 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.03336495 |
| 70 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.02562507 |
| 71 | Hepatitis B_Homo sapiens_hsa05161 | 1.02495973 |
| 72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.01989824 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 1.01314300 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 1.01008220 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 1.00078306 |
| 76 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99530397 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.99355096 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98270378 |
| 79 | Apoptosis_Homo sapiens_hsa04210 | 0.97884381 |
| 80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.97563541 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.97394388 |
| 82 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.97374554 |
| 83 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.97073079 |
| 84 | Salmonella infection_Homo sapiens_hsa05132 | 0.96881714 |
| 85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.96349013 |
| 86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.96304142 |
| 87 | Long-term depression_Homo sapiens_hsa04730 | 0.95544137 |
| 88 | Influenza A_Homo sapiens_hsa05164 | 0.95191608 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.94008645 |
| 90 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.92956925 |
| 91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91553452 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.91377727 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.90823758 |
| 94 | Morphine addiction_Homo sapiens_hsa05032 | 0.90597708 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.89082551 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.87960662 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.87954922 |
| 98 | Measles_Homo sapiens_hsa05162 | 0.87349247 |
| 99 | Renin secretion_Homo sapiens_hsa04924 | 0.86989290 |
| 100 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.86750295 |
| 101 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.86470180 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85091485 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.84526502 |
| 104 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83920691 |
| 105 | Colorectal cancer_Homo sapiens_hsa05210 | 0.83742553 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.82005038 |
| 107 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81977804 |
| 108 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.81732582 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79959839 |
| 110 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79744848 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79553491 |
| 112 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.79407397 |
| 113 | Lysosome_Homo sapiens_hsa04142 | 0.79206325 |
| 114 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78874769 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.78787839 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.78587991 |
| 117 | Adherens junction_Homo sapiens_hsa04520 | 0.78345805 |
| 118 | Prostate cancer_Homo sapiens_hsa05215 | 0.76807923 |
| 119 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76794597 |
| 120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.75656576 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75310601 |
| 122 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.75148704 |
| 123 | Endometrial cancer_Homo sapiens_hsa05213 | 0.75025014 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74864660 |
| 125 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74852718 |
| 126 | Tight junction_Homo sapiens_hsa04530 | 0.74469651 |
| 127 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.73498144 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73316803 |
| 129 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71840707 |
| 130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71808753 |
| 131 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71455033 |
| 132 | Endocytosis_Homo sapiens_hsa04144 | 0.70703867 |
| 133 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68781258 |
| 134 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68176248 |
| 135 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.68130002 |
| 136 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.67806424 |
| 137 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.67719069 |
| 138 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67512192 |
| 139 | Pertussis_Homo sapiens_hsa05133 | 0.67464874 |
| 140 | Melanogenesis_Homo sapiens_hsa04916 | 0.67441229 |
| 141 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67166578 |
| 142 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.67070696 |
| 143 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66542140 |
| 144 | Axon guidance_Homo sapiens_hsa04360 | 0.64975503 |
| 145 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64875946 |
| 146 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64293039 |
| 147 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63976572 |
| 148 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.62153088 |
| 149 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.61884198 |
| 150 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61870517 |
| 151 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60164448 |
| 152 | Bladder cancer_Homo sapiens_hsa05219 | 0.59188403 |
| 153 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59135691 |
| 154 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59095869 |
| 155 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58640136 |
| 156 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58430633 |
| 157 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57956064 |
| 158 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57828658 |
| 159 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.57288095 |
| 160 | Parkinsons disease_Homo sapiens_hsa05012 | 0.57139346 |
| 161 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56729375 |
| 162 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.55979038 |
| 163 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.54434666 |
| 164 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.53957675 |
| 165 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53727449 |
| 166 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53561962 |
| 167 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53022020 |
| 168 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.51366475 |

